MORGAN STANLEY

IBTimes Logo

Morgan Stanley cuts Devon to equal-weight

Morgan Stanley downgraded Devon Energy Corp to equal-weight from overweight, and said the U.S. exploration and production company would be hurt if there was a lag in the recovery of natural gas prices.
IBTimes Logo

European shares led lower by financials, D.Bank Q3

European shares fell for a second day on Wednesday, with financial stocks taking most points off the leading index after Deutsche Bank unexpectedly released quarterly figures that knocked its stock.
More news
IBTimes Logo

Banks jostle for commods talent as markets rebound

Rallying commodity markets are adding to profits of Wall Street houses like Goldman Sachs and JPMorgan, and banks are ramping up commodity desks again, a year after the recession cut into operations.
IBTimes Logo

Wall St weighed down by J&J, bank stocks

U.S. stocks weakened on Tuesday as disappointing sales from Johnson & Johnson stirred jitters about the strength of earnings, threatening to break the S&P 500's six-day winning streak.
IBTimes Logo

Despite bumps, demand remains for Asia IPOs -panel

Demand for public stock offerings in Hong Kong and throughout the region remains strong, despite a few recent deals that struggled, according to a panel of three investment bankers and one hedge fund investor.
IBTimes Logo

Citi to sell Phibro to Occidental, price seen low

Citigroup Inc agreed to sell its Phibro energy trading business to Occidental Petroleum Corp for a pittance, allowing the bank to calm regulators who were outraged over a $100 million pay package the unit was obliged to pay a star trader.
IBTimes Logo

JPMorgan, banks settle subprime suit for $100 mln

JPMorgan Chase & Co, Credit Suisse Group and Morgan Stanley have agreed to pay $100 million to settle a lawsuit over their role in the collapse of a Philadelphia mortgage lender, an attorney said on Friday.
IBTimes Logo

Biotech fundraising up amid vaccine hype, cash need

Hype about the swine flu vaccines, pent-up demand for cash and a push by major drugmakers to boost their flagging research pipelines has helped lift biotechnology fund-raising 36 percent so far this year.
IBTimes Logo

U.S. personal spending surges, jobless claims rise

U.S. consumer spending rose at its fastest pace in nearly 8 years in August, but the number of workers filing new claims for jobless benefits rose last week, indicating a weak labor market would weigh on recovery.
IBTimes Logo

Personal spending surges, jobless claims rise

U.S. consumer spending rose at its fastest pace in nearly 8 years in August, but the number of workers filing new claims for jobless benefits rose last week, indicating a weak labor market would weigh on recovery.
IBTimes Logo

Talecris prices IPO within range, ups deal size

Talecris Biotherapeutics Holdings Corp priced shares in its initial public offering for $19 each, within the expected range, but increased the size of the share issue in the largest IPO by a biopharmaceuticals firm in three years.
IBTimes Logo

UPDATE 1-Accretive Health aims for $200 mln IPO

Accretive Health Inc AH.N, a provider of technology and services aimed at helping hospitals manage their revenue cycles, plans to raise as much as $200 million in an initial public offering, according to a prospectus filed with U.S. regulators.
IBTimes Logo

RailAmerica IPO to price in October

RailAmerica Inc, which owns and operates short-line and regional freight railroads in North America, has set the terms for its planned initial public offering, which is scheduled for October.
IBTimes Logo

Morgan Stanley leads as M&A shows signs of life

Morgan Stanley is outrunning archrival Goldman Sachs as 2009's busiest adviser on mergers as optimism grows that the crippling effects of the financial crisis on dealmaking may be easing.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.